Monday, 19 March 2007

Med BioGene Announces Strategic Partnership with Duke University

Key to Med BioGene's success is securing research collaboration agreements with institutions to further develop and validate the genetic biomarkers. The institutions provide MBI with tissue samples from patients with clinically confirmed diseases, in this case lymphoma and leukemia. MBI uses the samples for genetic analysis to further validate its Gene Expression Profiling System. Today, MBI announced a strategic research collaboration and option agreement with Duke University, one of the world's most prestigious academic institutions.
Click here for the full details in the release.